价格

ACE2 protein variant

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

NOVEL CORONAVIRUS PROTECTIVE NASAL SPRAY, AND PREPARATION AND USE THEREOF
EP 4678663 A1申请人: SICHUAN CLOVER BIOPHARMACEUTICALS INC优先权: 2023
EP
US
WO
3 件公开
ANTIBODY BINDING TO RBD OF SPIKE PROTEIN OF SARS-COV-2 AND A METHOD FOR QUANTIFYING PROTECTIVE ANTIBODIES AGAINST SARS-COV-2
EP 4089112 A1申请人: USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I优先权: 2021
EP
WO
2 件公开
NCOVsiRNA drug for targeted delivery of shRNA by RBD
CN 114569712 A申请人: HANGZHOU DEMENTIA BIOTECHNOLOGY LTD COMPANY优先权: 2021
CN
2 件公开
抗新型冠状病毒人源化纳米抗体及其应用
CN 114805562 B申请人: 广东菲鹏制药股份有限公司优先权: 2022
CN
2 件公开
Compositions and methods for targeting coronaviruses using lipid vesicles including exosomes
CN 115484979 A申请人: UNIV TEXAS优先权: 2020
CN
CORONAVIRUS-DERIVED RECEPTOR BINDING DOMAIN VARIANT WITH REDUCED ACE2 BINDING CAPACITY, AND VACCINE COMPOSITION COMPRISING SAME
EP 4212544 A1申请人: GI CELL INC优先权: 2020
EP
Recombinant ACE2-FC fusion molecules and methods of making and using same
- CN 116710120 A
  申请人: SICHUAN BAILI PHARMACEUTICAL CO LTD优先权: 2020
  CN
- CN 115667506 A
  申请人: SYSTIMMUNE INC优先权: 2021
  CN
RECOMBINANT ACE2-FC FUSION MOLECULES AND METHODS OF MAKING AND USING THEREOF
US 2023250410 A1申请人: SYSTIMMUNE INC优先权: 2021
US
COMPOSITIONS AND USES OF SARS-COV-2 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED NK CELLS
US 2023303654 A1申请人: HOPE CITY优先权: 2021
US
Synthesis method of chemical drug nCoVshRNA.2RBD
CN 116254256 A申请人: HANGZHOU CHICHUANG BIOTECHNOLOGY CO LTD优先权: 2021
CN

药物

ACE2 protein variant

专利

Recombinant ACE2-FC fusion molecules and methods of making and using same